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Abstract: Strengthening the lumbar extensor musculature is a common recommendation for chronic
low back pain (CLBP). Although reported as effective, variability in response in CLBP populations
is not well investigated. This study investigated variability in responsiveness to isolated lumbar
extension (ILEX) resistance training in CLBP participants by retrospective analysis of three previous
randomized controlled trials. Data from 77 participants were available for the intervention arms
(males = 43, females = 34) 37 participants data (males = 20, females = 17) from the control arms.
Intervention participants had all undergone 12 weeks of ILEX resistance training and changes in
ILEX strength, pain (visual analogue scale; VAS), and disability (Oswestry disability index; ODI)
measured. True inter-individual (i.e., between participants) variability in response was examined
through calculation of difference in the standard deviation of change scores for both control and
intervention arms. Intervention participants were classified into responder status using k-means
cluster analysis for ILEX strength changes and using minimal clinically important change cut-offs for
VAS and ODI. Change in average ILEX strength ranged 7.6 Nm (1.9%) to 192.1 Nm (335.7%). Change
in peak ILEX strength ranged −12.2 Nm (−17.5%) to 276.6 Nm (169.6%). Participants were classified
for strength changes as low (n = 31), medium (n = 36), and high responders (n = 10). Change in
VAS ranged 12.0 mm to −84.0 mm. Participants were classified for VAS changes as negative (n = 3),
non-responders (n = 34), responders (n = 15), and high responders (n = 19). Change in ODI ranged
18 pts to −45 pts. Participants were classified for ODI changes as negative (n = 2), non-responders
(n = 21), responders (n = 29), and high responders (n = 25). Considerable variation exists in response
to ILEX resistance training in CLBP. Clinicians should be aware of this and future work should
identify factors prognostic of successful outcomes.
Keywords: rehabilitation; deconditioning; individual response; heterogeneity
1. Introduction
Chronic low back pain (CLBP) is one of the most prevalent medical disorders in today’s
societies [1,2] representing an enormous economic cost worldwide [3–6]. Exercise is a common
prescription for CLBP. This is despite the fact that previous Cochrane reviews have generally reported
small effect sizes for most exercise approaches, reflecting either low average outcomes or high
Healthcare 2017, 5, 75; doi:10.3390/healthcare5040075 www.mdpi.com/journal/healthcare
Healthcare 2017, 5, 75 2 of 15
variability in outcomes [7,8]. But, these reviews have typically considered “exercise” as a single
class of treatment without consideration to the varied exercise approaches that exist. The Cochrane
reviews have not adequately described, defined and categorized the “exercise” studies they have
examined and have been specifically criticized for this flaw and their wide-sweeping conclusions [7–10].
Though, this may be because many empirical studies of exercise in CLBP in fact lack an adequate
description of the precise exercises used [11,12]. However, Searle et al. [13] recently examined the
impact of different exercise types reporting that resistance training and motor control type exercises
may offer the greatest benefits.
A general approach to exercise is further confounded by the fact that CLBP is a multifactorial
condition [14,15]. Numerous models attempting to explain, predict, and integrate the multifactorial
elements of CLBP have emerged within the literature [16–18]. Indeed, due to the multifactorial nature
of CLBP, sub-grouping (i.e., splitting of the larger heterogeneous population of CLBP into smaller
more homogenous groups) has been argued to aid in directing treatment [19–21].
Despite this, it has been suggested that specific deconditioning of the extensor muscles of the
lumbar spine (lumbar extensor musculature i.e., thoracic and lumbar erector spinae, including the
iliocostalis lumborum and longissimus thoracis, the multifidus, and also the quadratus lumborum
when contracted bilaterally) may be a general risk factor for low back injury and pain [22–24].
Indeed, a recent review concluded that deconditioning of these muscles (reduced lumbar extension
strength/endurance, atrophy, and excessive fatigability) is common in CLBP, and that this may be
involved in many of the multifactorial symptoms and dysfunctions present [25].
As such, exercise designed to specifically condition this musculature (i.e., develop strength,
endurance and hypertrophy [22,24,26,27] is often recommended. However, even within this category
of exercise there exists a number of different approaches including: bench and roman chair trunk
extensions (TEX), use of free weights (e.g., deadlifts, squats, good mornings), floor and stability ball
exercise (e.g., TEX, bridging, 4-point kneeling), and resistance machines including those with and
without restraints for isolated lumbar extension (ILEX) exercise [12]. Many of these approaches lack
evidence for efficacy in conditioning the lumbar extensors; though resistance machines providing ILEX
appear to be the exception [28]. A review of studies utilizing ILEX resistance training in CLBP suggests
it produces statistically significant improvements in ILEX strength, pain, and disability, which also
consistently meet minimal clinically important change values [29].
Resistance training in general, regardless of resistance type, commonly follows a general
prescription [30,31] and often focuses on certain exercises to condition a specific muscle group such as
ILEX [28]. A recent study comparing individualized low load motor control exercise with high load
deadlift resistance training following a general approach reported no difference between groups for
most outcomes in a homogenous population of participants with nociceptive mechanical CLBP [32].
An early study using ILEX resistance training also found that specific sub-grouping did not affect
group outcomes, despite all participants receiving the same intervention [33]. Although, considering
the heterogeneity of CLBP it might be expected that there would be at least some variability in the
responsiveness of individuals to different treatments. Nelson et al. [33] also asked their participants to
rate pain changes after an ILEX intervention on a 5-item scale (“worse”, “no change”, “slight decrease”,
“decreased”, “substantially decreased”) reporting 64% rated a substantial decrease, 14% rated a
decrease, 6% rated a slight decrease, 12% rated no change, and 3% rated a worsening of symptoms.
Though in terms of average group outcomes exercise such as ILEX appears to be effective [29], the
degree of variability in response in CLBP populations is not well investigated or understood.
Considering the paucity of data in this area it is of interest to investigate and further characterize
the variability in responsiveness to ILEX treatment in CLBP participants. Such information is useful
in helping consider characteristics which might influence response to training interventions in this
population. The authors of the present piece have previously conducted a series of studies in which
participants with CLBP have all undergone similar 12 weeks ILEX interventions, or corresponding
control periods, and been examined for the same outcomes. Here the pooled data from these studies
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are reported with the aim of characterizing the variability in response of changes in ILEX strength,
pain, and disability. It was hypothesized that there would likely be considerable true inter-individual
(i.e., between participants) variation in responsiveness to ILEX resistance training in participants with
CLBP due to the heterogeneity of the condition.
2. Materials and Methods
2.1. Experimental Approach to the Problem
The present study retrospectively examined data pooled from three previous trials of ILEX
resistance training in participants with CLBP [34–36]. Participant data were extracted from
the intervention arms of these studies that underwent 12 weeks ILEX interventions. In both
Bruce-Low et al. [34] and Steele et al. [35] two manipulations of ILEX resistance training were examined
(frequency and range of motion respectively), however, both studies found no difference between the
two intervention arms of each trial. Thus all ILEX resistance training intervention and control arms of
these trials were included. All participants in each trial had given their informed consent for inclusion
before they participated in the study. Each study was conducted in accordance with the Declaration of
Helsinki, and each study received individual ethical approval by the Ethics Committees of the lead
author’s institution (11/40504/9).
Participants
A total of 77 participants data were available from the intervention arms (males = 43, females = 34)
and a total of 37 participants data (males = 20, females = 17) from the control arms of the three combined
trials. Participants had been recruited through posters, group emails, and word of mouth from the
University and locality. In all trials participants had continued with any other treatments they were
currently receiving, including medication, per recommendations from the reviewing ethics committee.
Participants were however instructed to avoid beginning any other resistance training exercises
designed to condition the lumbar extensor musculature. Inclusion criteria for each trial were as follows:
participants who experienced nonspecific low back pain having lasted longer than 12 weeks and had no
medical condition contraindicating resistance training. Exclusion criteria were any medical condition
for which movement therapy might be contraindicated. These included acute (not reoccurring) low
back injury occurring within the last 12 weeks, pregnancy, evidence of sciatic nerve root compression
(sciatica), leg pain radiating to below the knee, paresthesia (tingling or numbness), current tension
sign, lower limb motor deficit, current disc herniation, previous vertebral fractures, or other major
structural abnormalities. In all trials participants were cleared to exercise by their general practitioner,
physiotherapist, or chiropractor and provided written informed consent.
2.2. Procedures and Protocols
2.2.1. Equipment
In all trials isometric strength testing and training for ILEX was performed using the MedX
Lumbar Extension Machine (MedX, Ocala, FL, USA; Figure 1) which has been shown as reliable in
both asymptomatic (r = 0.81–0.97 [37]) and symptomatic participants (r = 0.57–0.93 [38]) and is valid
in measurement [39,40]. Pain was measured using a 100-mm visual analogue scale (VAS [41]) and
disability measured using the revised Oswestry Disability Index (ODI [42]).
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were collected both before and after the intervention on the first and second to last visits to the 
laboratory where testing and training was conducted. 
2.2.3. Training for Intervention Arms 
Training in all trials was conducted at a frequency of once [34–36] or, in the case of one of the 
training groups in Bruce-Low et al. [34], twice a week for 12 weeks. Participants performed a single 
set of variable resistance ILEX exercise through either a full [34–36] or limited (mid 50%) range of 
motion [35]. Resistance load was 80% of maximum isometric torque during baseline testing and 
participants performed repetitions until momentary concentric failure such that effort was controlled 
[43]. In the trial of Bruce-Low et al. [34] in the second weekly session participants performed a single 
set using 50% of their maximum isometric torque for 105–140 s and did not continue to momentary 
concentric failure. All repetitions were performed taking at least 2 s to complete the concentric phase, 
holding for 1 second in full extension, and taking at least 4 s to complete the eccentric phase. 
Resistance load in the set to momentary concentric failure was increased by 5% when participants 
were able to continue exercise for more than 105 s before reaching failure using their current load. 
2.3. Statistical Analysis 
Data for change as a result of the intervention (post minus pre) for the following outcomes were 
extracted from the trials: the average of ILEX strength across the angles tested, peak ILEX strength, 
ILEX strength index (calculated as the area under the curve of all angles tested using the trapezoidal 
method), VAS, and ODI. Normality of distribution was examined using the Shapiro-Wilk test. 
Variability within the cohort was examined for each outcome variable in several ways. Firstly, 
methods described by Atkinson and Batterham [44] were used to determine to examine whether true 
inter-individual variability in responses existed in the interventions arms independent of within-
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2.2.2. Testing
In all trials isometric strength testing for ILEX was tested twice on separate days (at least 72 h apart
to void residual fatigue or soreness) before and after the intervention. Each test involved maximal
voluntary isometric contractions at various angles through the participant’s full range of motion.
Briefly, after an initial light warmup and practice test at 50% of maximal perceived effort, participants
performed iso etric contractions where they increased effort gradually over a 3-second period until
maximal. The restraint system was signed to prevent pelvic movement so that ILEX fu ction could
be tested indep ndently. Details f th full-test protocol and its restraint system (Figure 1) have
previously been documented elsewh e [37]. VAS (0 to 100 mm) and ODI (0 to 100 pt ) were c llected
both before and after the intervention on the first and second to last visits to the laboratory where
testing and training was conducted.
2.2.3. Training for Intervention Arms
Training in all trials was conducted at a frequency of once [34–36] or, in the case of one of
the training groups in Bruce-Low et al. [34], twice a week for 12 weeks. Participants performed a
single set of variable resistance ILEX exercise through either a full [34–36] or limited (mid 50%) range
of motion [35]. Resistance load was 80% of maximum isometric torque during baseline testing
and participants performed repetitions until momentary concentric failure such that effort was
controlled [43]. In the trial of Bruce-Low et al. [34] in the second weekly session participants performed
a single set using 50% of their maximum isometric torque for 105–140 s and did not continue to
momentary concentric failure. All repetitions were performed taking at least 2 s to complete the
concentric phase, holding for 1 second in full extension, and taking at least 4 s to complete the
eccentric phase. Resistance load in the set to momentary concentric failure was increased by 5% when
participants were able to continue exercise for more than 105 s before reaching failure using their
current load.
2.3. Statistical Analysis
Data for change as a result of the intervention (post minus pre) for the following outcomes were
extracted from the trials: the average of ILEX strength across the angles tested, peak ILEX strength, ILEX
strength index (calculated as the area under t e curve of all angles tested using the trapezoidal method),
VAS, and ODI. Normality of dist ibution was examined using the Shapiro-Wilk test. Variability within
the cohort was examined for each outcome variable in several ways. Firstly, methods described
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by Atkinson and Batterham [44] were used to determine to examine whether true inter-individual
variability in responses existed in the interventions arms independent of within-participant random
variation. The difference in standard deviations of the changes in each outcome was calculated using
the following equation: √
σi2 − σc2
where σi is the standard deviation of the change scores for the intervention groups, and σc is the
standard deviation of the change scores for the control groups. If the difference in standard deviations
of the changes scores between the intervention and control groups is similar (i.e., close to zero) then no
clinically important individual responses are evident. Where these were deemed to differ meaningfully
from zero (considered as a difference in standard deviation favouring variability in the intervention
arm approximately half of the mean change score), further analyses were conducted to attempt to
categorise the nature of the individual responses in the intervention arms.
For each variable the coefficient of variation and each resultant distribution was described in
terms of skewness and kurtosis. Data were pooled for each variable and rank ordered to identify
the range for each outcome variable. From this bins were created at regular intervals and data were
plotted as a histogram showing percentage of participants achieving the defined values for each bin.
Histograms were produced using the data analysis toolbox in Microsoft Office Excel 2013 (Microsoft
Corporation, Redmond, WA, USA). To further illustrate the distributions of the data Shapiro-Wilk
testing, skewness and kurtosis was calculated using IBM SPSS Statistics for Windows (version 20;
IBM Corp, Portsmouth, Hampshire, UK) and p ≤ 0.05 set as the limit for statistical significance.
Lastly, responder status was also classified for outcome variables. For ILEX strength changes (both
average, peak, and strength index) k-means cluster analysis was used to classify participants as either
“low responders”, “medium responders”, or “high responders”. For VAS and ODI minimal clinically
important change (MCIC) values as suggested by Ostelo et al. [45] were used to classify participants as
either “negative responders” (increase in VAS or ODI), “non-responders” (reduction in VAS or ODI
that did not meet MCIC), “responders” (reduction in VAS or ODI that met MCIC), or “high responders”
(reduction in VAS or ODI that met double the MCIC).
3. Results
3.1. Participant Demographics
Demographic data were pooled from the included trials. Baseline demographics are presented in
Table 1 for both control and intervention arms.
Table 1. Participant baseline demographic data (Mean ± SD).
Variable Control Arms (n = 37) Intervention Arms (n = 77)
Age (years) 47 ± 14 46 ± 14
Stature (cm) 172.5 ± 10.0 171.3 ± 8.1
Body Mass (kg) 79.6 ± 16.4 77.2 ± 14.0
Body Mass Index (kg·m2) 26.5 ± 3.8 26.1 ± 3.2
Symptom duration (years) 14 ± 13 14 ± 13
VAS (mm) 26.9 ± 15.2 36.0 ± 21.6
ODI (pts) 30.0 ± 8.2 30.8 ± 12.8
Average ILEX Strength (Nm) 202.5 ± 99.7 198.9 ± 93.5
Peak ILEX Strength (Nm) 272.7 ± 135.0 276.1 ± 129.5
ILEX Strength Index (Nm) 13847.6 ± 6811.4 13078.0 ± 6780.9
VAS = visual analogue scale; ODI = Oswestry disability index; ILEX = isolated lumbar extension.
3.2. Presence of True Inter-Individual Responses
All outcomes were considered to show evidence of true and meaningful inter-individual responses
in the intervention arms (considered as a difference in standard deviation favouring variability in the
Healthcare 2017, 5, 75 6 of 15
intervention arm approximately half of the mean change score). Table 2 shows the calculated difference
between the standard deviations of the change scores of intervention and control arms. Figure 2 shows
the individual response plots along with the mean and standard deviations of the changes scores
for each outcome in the control and intervention arms for visual comparison of the variation within
each arm.
Table 2. Calculated differences between standard deviations (σ) of changes scores between control and
intervention arms and comparison to mean intervention and control change scores.
Variable Difference (
√
œi2 − œc2) Mean Intervention Change Score Mean Control Change Score
VAS (mm) 13.0 −19.1 2.5
ODI (pts) 6.4 −14.4 −1.1
Average ILEX Strength (Nm) 39.5 67.5 −0.2
Peak ILEX Strength (Nm) 49.8 74.2 −4.7
ILEX Strength Index (Nm) 3022.4 4879.7 −37.2
VAS = visual analogue scale; ODI = Oswestry disability index; ILEX = isolated lumbar extension.
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3.3. ILEX Strength
Mean change in average ILEX strength was 67.5 Nm (42.5%) and ranged from 7.6 Nm (1.9%)
to 192.1 Nm (335.7%). Change in average ILEX strength did not meet assumptions of normality
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of distribution when examined using the Shapiro-Wilk test (p ≤ 0.001). Coefficient of variation for
change in average ILEX strength was 68.6% and the distribution showed a skewness of 1.1 and
kurtosis of 0.6 (Figure 3). Mean change in peak ILEX strength was 74.2 Nm (29.2%) and ranged from
−12.2 Nm (−17.5%) to 276.6 Nm (169.6%). Change in peak ILEX strength did not meet assumptions
of normality of distribution when examined using the Shapiro-Wilk test (p ≤ 0.001). Coefficient of
variation for change in peak ILEX strength was 76.5% and the distribution showed a skewness of
1.5 and kurtosis of 2.8 (Figure 4). Mean change in ILEX strength index was 4879.7 Nm (53.2%) and
ranged from −1054.3 Nm (−17.5%) to 16,082.7 Nm (169.6%). Change in peak ILEX strength did not
meet assumptions of normality of distribution when examined using the Shapiro-Wilk test (p = 0.001).
Coefficient of variation for change in peak ILEX strength was 76.5% and the distribution showed a
skewness of 1.0 and kurtosis of 1.2 (Figure 5).
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and 19 participants considered as high responder (note: some data points were missing from original
records for VAS in the study of Bruce-Low et al. [34]).
3.5. Disability
Mean change in ODI was −14.4 pts and ranged from 18 pts to −45 pts. Change in ODI did not
meet assumptions of normality of distribution when examined using the Shapiro-Wilk test (p = 0.049).
Coefficient of variation for change in ODI was 72.4% and the distribution showed a skewness of 0.2
and kurtosis of 1.8 (Figure 7).
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random within-participa t variation. This study seems to be the first to ocument this in a moderately
sized sample of participants with CLBP who had undergone 12 weeks of controlle ILEX resistance
training based exercise. These results show there is true inter-individual variability in responses to
an ILEX resistance training intervention with respect to strength, pain, and disability outcomes as
evidenced by the meaningful differences between the standard deviatio of changes scores between
control and intervention arms in the studies examined. As s ch, the nature of this variability in
outcomes was examined further.
I base interventions are tho ght to ork thro gh the con itioning effect they have on
the l bar extensor sc lat re [11,12,29]. his is tho ght to reverse the econ itioning of this
usculature that ay be present in those ith LBP [25]. s such, the variability in strength changes
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as a result of the ILEX intervention was examined here. Though not all participants showed an increase
in peak ILEX strength or ILEX strength index as a result of the intervention there was an increase
in average ILEX strength in all 77 participants examined. Despite this, the range of strength gains
was wide in all strength outcome changes and reflects the considerable heterogeneity in response.
It is well documented that strength gains after resistance training vary considerably amongst healthy
individuals [46]. In terms of relative changes, Hubal et al. [46] reported a similar range of responses to
those reported here, including some participants who showed decreases in isometric strength.
However, the coefficients of variation reported by Hubal et al. [46] are considerably lower (0.6%
to 1.0%) than those reported here (68.6% to 76.5%). This may be reflective of the sample sizes in
the respective studies; Hubal et al. [46] had 585 participants whereas the present study had 77.
Alternatively, it may indicate that the variation in response to training is considerably higher in
certain populations such as those with CLBP. Indeed, our cluster analysis revealed that the majority of
participants (n = 50; 64%) could be considered as ‘low responders’ versus only a very small minority
who were “high responders” (n = 5; 6%). Though their method of classifying responder status is not
entirely clear, Hubal et al. [46] reported only 2.6% to 3.4% of their participants were considered low
responders. It should be considered that most studies, including Hubal et al. [46], examining such
variability in responses have not included a control arm in order to characterize “true” and meaningful
response variation. Nevertheless, the differences in strength change variation between the study of
Hubal and colleagues [46] and the present study may suggest that populations with CLBP may be
inherently less responsive than asymptomatic populations in terms of strength gains.
This may be important as improved ILEX strength is thought to be the active mechanism through
which improvements in pain and disability occur with ILEX resistance training interventions [11,12,29].
Indeed, some studies have reported an association between change in ILEX strength and improvement
in pain [33,35]. Though, at least one has reported no significant association between these outcomes [47].
Thus whether or not a person’s ILEX strength improves or not as a result of an intervention may not
be a good indicator of the success or failure of the intervention. However, it has been shown that
ILEX strength is associated with outcomes such as lift capacity [48,49]. Thus, whether or not a person
undergoing ILEX training has a substantial increase in ILEX strength may have implications for their
wider functioning.
The reason for such variability and overall low response in strength is not clear from our results
specifically. However, it may relate to fear avoidance beliefs. Al-Obaidi et al. [50] reported that fear
avoidance beliefs were a prognostic factor for whether participants met MCICs for improvements in
disability. It has also been shown that improvements in disability may be related to improvements in
ILEX strength [35]. Participants undergoing the ILEX intervention in the studies included here were
encouraged to train to momentary concentric failure (i.e., maximal effort); this due to the suggestion
it might produce optimal strength and muscular adaptation [30,31]. However, it is possible that
many may have not achieved momentary concentric failure, instead stopping short at a point they
considered volitional failure due to fear avoidance beliefs. Recent studies have shown that stopping
repetitions short of achieving momentary failure produces sub-optimal strength gains [51,52]. Further,
a study examining ILEX resistance training in participants with CLBP where frequency, load, and
effort where not controlled reported no change in multifidus cross sectional area [53]. Conversely,
those which have had CLBP participants perform ILEX exercise to momentary failure have reported
significant multifidus hypertrophy [54,55]. It is possible that a majority of participants did not train
with a sufficient degree of effort to induce optimal muscular adaptations [56].
It is surprising that there is relatively little literature reporting variation in response to exercise
based interventions for CLBP. Particularly as it is common for many practitioners to see patients
who respond poorly or even negatively to treatments. Conversely, it is also known that some
participants respond inexplicably well. Identifying whether such variation is indeed a result of
inter-individual responsiveness and not merely random within-participant variation is of importance.
Further, understanding the expected degree of variation in pain and disability outcomes as a result of
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exercise intervention might help guide practitioners to choose those which are more likely to produce
favorable outcomes in the widest range of patients. The results presented here highlight there is
considerable variation in responsiveness to ILEX resistance training for changes in pain and disability.
This variation, in agreement with the strength outcomes, was similarly high (coefficients of variation
were 93.2% and 72.3% for VAS and ODI respectively). Indeed, a considerable proportion of participants
were either ‘negative responders’ or ‘non responders’ for both VAS (n = 37; 52%) and ODI (n = 23; 30%).
However, in contrast to the strength data responder classifications, a large proportion of participants
met MCICs and thus were considered as “responders” for VAS (n = 15; 21%) and ODI (n = 29; 37%).
Further, a large proportion of participants achieved outcomes in excess of double the MCICs and were
considered as ‘high responders’ for both VAS (n = 15; 27%) and ODI (n = 15; 33%). This would appear
to support the experience of many practitioners as mentioned; some people respond inexplicably
poorly or well to the same intervention.
These data would seem to agree with those reported by Nelson et al. [33] who found that a
considerable proportion of participants reported a “substantial decrease” in their pain after an ILEX
resistance training based intervention. As Nelson et al. [33] utilized a subjective global perceived
outcome based scale it is difficult to compare their results directly to the classification here based upon
MCICs. However, their range of responses appears similar. Despite there being a large proportion of
persons who evidently respond well to ILEX interventions it is concerning to see a large proportion
not achieving the MCICs, and also that some participants respond negatively. Why this is the case and
whether or not these persons would do better with an alternative intervention is not clear. However,
many argue that more positive outcomes may occur from interventions that are individualized
based on sub grouping to the person receiving them [19,57]. As noted, some work has shown that
psycho-social factors may play a prognostic role in determining whether persons will meet MCICs
from exercise interventions, and specifically ILEX [50]. It is not yet clear whether this is a determinant
of clinical improvement, or an effect of the intervention [56,58]. Yet, this does pose the question of
whether or not characteristics can be identified that enable clinicians to predict success or failure with
a particular intervention.
Thus far this concept currently has had little validating evidence to support it [59]. However,
this may be due to inappropriate sub-grouping of participants in earlier studies [19,57]. The present
study included participants broadly classified as having nonspecific CLBP with only certain red flag
presentations excluded. As such, this sample likely represents the typical heterogeneity of CLBP and
thus the true variation in responsiveness seen here may be a result of this.
The results presented reveal the considerable variation in response to ILEX resistance training
in participants with CLBP. Range of variance in strength gains was similar to that seen in healthy
persons and all participants increased in strength. However, the actual variance suggested that
change in strength for persons with CLBP is more heterogeneous and that a considerable proportion
of persons could be considered as “low responders” and only a very small proportion as “high
responders”. Contrastingly, for pain and disability, though a significant proportion of participants did
not meet MCICs and thus were considered “non responders”, a large proportion did meet MCICs,
and a similarly large proportion exceeded these by more than double. From this it can be concluded
that, though considering group average outcomes ILEX resistance training significantly improves
pain and disability, some participants evidently respond far better than others. The reasons for this
variation are not presently clear though may relate to the heterogeneity of symptoms experienced by
persons with CLBP. It has been suggested that better methodologies for development and validation
of classification tools are required to properly test the value of classification. This would include
tandem utilization of both statistical and judgmental approaches to classification using a range
of dimensions including patho-anatomical, symptomology, psychological and social. In addition
to studies considering predictive validity of classification systems to produce desirable treatment
responses [19]. This is certainly a route for future research and indeed trials have been proposed for this
purpose [60–63]. Thus, the true variation in response identified here suggests that future work should
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consider this and look to identify characteristics that are prognostic of successful outcomes with ILEX
resistance training. These might then help practitioners sub group and make better treatment decisions.
Limitations of the present investigation should be noted. For example, participants in the included
studies were instructed to continue with any other treatments or therapies they were currently receiving
but to avoid any new ones. Further, the specific nature of the symptoms (e.g., specific location) or
details of the history of the participants CLBP occurrence (e.g., first occurrence), although considered
in screening participants for exclusion criteria, were not documented for consideration in our analyses.
This, in addition to other potential anatomical sources of pain, could thus not be considered and
may have also influenced the variation in responses. As such, there could have been confounding
variables in the present analysis. This was however the case for both intervention and control arms
in all trials. Lastly, the sample size included here was relatively speaking small for the purposes of
examining inter-individual responses. Such studies often include large sample sizes (e.g., n > 1000) [44].
The general lack of studies examining ILEX interventions means that there is less data available
rendering difficulty in achieving this number of participants. However, small sample sizes are
more likely to result in a negative difference in individual responses (i.e., one which favors greater
inter-individual variation in the control arm) [44]. Our data instead consistently suggested greater
variation in responses was present in the intervention arm.
5. Conclusions
A considerable proportion of persons with CLBP could be considered as ‘low responders’ and
only a very small proportion as ‘high responders’ for changes in strength after ILEX resistance training.
Contrastingly, for pain and disability, though a significant proportion of participants did not meet
MCICs and thus were considered “non responders”, a large proportion did meet minimal clinically
important changes and a similarly large proportion exceeded these by more than double. Though
group average outcomes to ILEX resistance training appear favorable some participants evidently
respond far better than others. The reasons for this variation are may relate to the heterogeneity of
symptoms experienced by persons with CLBP. An important limitation in the studies examined was
that participants were labelled as “non-specific”. Sub-grouping was not performed and may have
implications for responsiveness to ILEX resistance training interventions. Thus, practitioners should
expect that their clients might respond differently to interventions aimed at conditioning the lumbar
extensor musculature and at present it might be most prudent to consider ongoing evaluation of pain
and disability outcomes during an intervention to discern whether or not continuation is worthwhile.
For example, if after a period of intervention a participant is not responding as desired then it may be
worth considering changing to an alternative intervention approach, or stopping intervention entirely.
Acknowledgments: No funding was received in support of this research.
Author Contributions: James Steele, James Fisher, Stewart Bruce-Low, and Dave Smith conceived and designed
the original experiments; James Steele, Stewart Bruce-Low, Neil Osborne, and Dave Newell conceived of the
secondary analysis of the original data; James Steele, James Fisher, Stewart Bruce-Low performed the original
experiments; James Steele analysed the data; Neil Osborne contributed analysis tools; James Steele drafted
the manuscript; James Fisher, Stewart Bruce-Low, Dave Smith, Neil Osborne, and Dave Newell reviewed and
provided critical feedback regarding the manuscript.
Conflicts of Interest: The authors declare no conflicts of interest.
References
1. National Institute for Health and Clinical Excellence. Low Back Pain: Early Management of Persistent
Non-Specific Low Back Pain; Royal College of General Practitioners: London, UK, 2009.
2. Walker, B.F. The prevalence of low back pain: A systematic review of the literature from 1966 to 1998. J. Spinal
Disord. 2000, 13, 205–217. [CrossRef] [PubMed]
Healthcare 2017, 5, 75 13 of 15
3. Freburger, J.K.; Holmes, G.M.; Agans, R.P.; Jackman, A.M.; Darter, J.D.; Wallace, A.S.; Castel, L.D.;
Kalsbeek, W.D.; Carey, T.S. The rising prevalence of chronic low back pain. Arch. Intern. Med. 2009,
169, 251–258.
4. Guo, H.R.; Tanaka, S.; Halperin, W.E.; Cameron, L.L. Back pain prevalence in US industry and estimates of
lost workdays. Am. J. Public Health 1999, 89, 1029–1035. [CrossRef] [PubMed]
5. Maniadakis, N.; Gray, A. The economic burden of back pain in the UK. Pain 2000, 84, 95–103. [CrossRef]
6. Ricci, J.A.; Stewart, W.F.; Chee, E.; Leotta, C.; Foley, K.; Hocberg, M.C. Back pain exacerbations and lost
productive time costs in United States workers. Spine 2006, 31, 3052–3060. [CrossRef] [PubMed]
7. Hayden, J.; Van Tulder, M.W.; Malmivaara, A.; Koes, B.W. Exercise therapy for no-specific low back pain.
Cochrane Database Syst. Rev. 2005, 3, CD000335.
8. Van Tulder, M.W.; Malmivaara, A.; Esmail, R.; Koes, B.W. Exercise therapy for low back pain.
Cochrane Database Syst. Rev. 2000, 2, CD00335.
9. Manniche, C.; Jordan, A. Letter to the editor. Spine 2001, 26, 842–843. [CrossRef] [PubMed]
10. Manniche, C.; Jordan, A. Letter to the editor. Spine 2001, 26, 994. [CrossRef] [PubMed]
11. Helmhout, P.H.; Staal, J.B.; Maher, C.G.; Petersen, T.; Rainville, J.; Shaw, W.S. Exercise therapy and low back
pain: Insights and proposals to improve the design, conduct, and reporting of clinical trials. Spine 2008, 33,
1782–1788. [CrossRef] [PubMed]
12. Mayer, J.; Mooney, V.; Dagenais, S. Evidence informed management of chronic low back pain with lumbar
extensor strengthening exercises. Spine J. 2008, 8, 96–113. [CrossRef] [PubMed]
13. Searle, A.; Spink, M.; Ho, A.; Chuter, V. Exercise interventions for the treatment of chronic low back pain:
A systematic review and meta-analysis of randomised controlled trials. Clin. Rehabil. 2015, 29, 1155–1167.
[CrossRef] [PubMed]
14. National Research Council. Work-Related Musculoskeletal Disorders: A Review of the Evidence; National
Academy Press: Washington, DC, USA, 1998.
15. National Research Council and the Institute of Medicine. Musculoskeletal Disorders and the Workplace: Low Back
and Upper Extremities; National Academy Press: Washington DC, USA, 2001.
16. Hodges, P.W.; Smeets, R.J. Interaction between pain, movement and physical activity: Short-term benefits,
long-terms consequences, and targets for treatment. Clin. J. Pain 2015, 31, 97–107. [CrossRef] [PubMed]
17. Langevin, H.M.; Sherman, K.J. Pathophysiological model for chronic low back pain integrating connective
tissue and nervous system mechanisms. Med. Hypotheses 2007, 68, 74–80. [CrossRef] [PubMed]
18. Richmond, J. Multi-factorial causative model for back pain management; relating causative factors and
mechanisms to injury presentations and designing time- and cost effective treatment thereof. Med. Hypotheses
2012, 79, 232–240. [CrossRef] [PubMed]
19. Ford, J.; Story, I.; O’Sullivan, P.; McMeeken, J. Classification systems for low back pain: A review of the
methodology for development and validation. Phys. Ther. Rev. 2007, 12, 33–42. [CrossRef]
20. Hepple, P.; Robertson, A.R.R. Back pain-reducing long term problems. Br. J. Gen. Pract. 2006, 56, 324–326.
[PubMed]
21. Lebouef-Yde, C.; Lauritsen, J.M.; Lauritzen, T. Why has the search for causes of low back pain largely been
nonconclusive? Spine 1997, 22, 877–881. [CrossRef]
22. Carpenter, D.M.; Nelson, B.W. Low back strengthening for the prevention and treatment of low back pain.
Med. Sci. Sports Exerc. 1999, 31, 18–24. [CrossRef] [PubMed]
23. Pollock, M.L.; Leggett, S.H.; Graves, J.E.; Jones, A.; Fulton, M.; Cirulli, J. Effect of resistance training on
lumbar extension strength. Am. J. Sports Med. 1989, 17, 624–629. [CrossRef] [PubMed]
24. Smith, D.; Bruce-Low, S.; Bissell, G. Twenty years of specific, isolated lumbar extension research: A review.
J. Orthop. 2008, 5, 14.
25. Steele, J.; Bruce-Low, S.; Smith, D. A reappraisal of the deconditioning hypothesis in low back pain: Review
of evidence from a triumvirate of research methods on specific lumbar extensor deconditioning. Curr. Med.
Res. Opin. 2014, 30, 865–911. [CrossRef] [PubMed]
26. DeLorme, T.L. Restoration of muscle power by heavy-resistance exercises. J. Bone Jt. Surg. 1945, 27, 645.
27. DeLorme, T.L.; Watkins, A.L. Technics of progressive resistance exercise. Arch. Phys. Med. Rehabil. 1948, 29,
263–273. [PubMed]
28. Steele, J.; Bruce-Low, S.; Smith, D. A review of the specificity of exercises designed for conditioning the
lumbar extensors. Br. J. Sports Med. 2015, 49, 291–297. [CrossRef] [PubMed]
Healthcare 2017, 5, 75 14 of 15
29. Steele, J.; Bruce-Low, S.; Smith, D. A review of the clinical value of isolated lumbar extension resistance
training for chronic low back pain. PM&R 2015, 7, 169–187.
30. Fisher, J.; Steele, J.; Bruce-Low, S.; Smith, D. Evidence based resistance training recommendations. Med. Sport.
2011, 15, 147–162. [CrossRef]
31. Fisher, J.; Steele, J.; Smith, D. Evidence based resistance training recommendations for muscular hypertrophy.
Med. Sport 2013, 17, 217–235.
32. Aasa, B.; Berglund, L.; Michaelson, P.; Aasa, U. Individualised low-load motor control exercises and education
versus a high-load lifting exercise and education to improve activity, pain intensity, and physical performance
in patients with low back pain: A randomized controlled trial. J. Orthop. Sports. Phys. Ther. 2015, 45, 77–85.
[CrossRef] [PubMed]
33. Nelson, B.W.; O’Reilly, E.; Miller, M. The clinical effects of intensive, specific exercise on low back pain:
A controlled study of 895 consecutive patients with a one year follow up. Orthopedics 1995, 18, 971–981.
[PubMed]
34. Bruce-Low, S.; Smith, D.; Burnet, S.; Fisher, J.; Bissell, G.; Webster, L. One lumbar extension training session
per week is sufficient for optimal strength gains and reductions in low back pain in chronic participants.
Ergonomics 2012, 55, 500–507. [CrossRef] [PubMed]
35. Steele, J.; Bruce-Low, S.; Smith, D.; Jessop, D.; Osborne, N. A Randomised Controlled Trial of Limited Range
of Motion Lumbar Extension Exercise in Chronic Low Back Pain. Spine 2013, 38, 1245–1252. [CrossRef]
[PubMed]
36. Steele, J.; Bruce-Low, S.; Smith, D.; Jessop, D.; Osborne, N. Isolated lumbar extension resistance training
improves strength, pain, and disability, but not spinal height or shrinkage (‘creep’) in participants with
chronic low back pain. Cartilage 2017. [CrossRef]
37. Graves, J.E.; Pollock, M.L.; Carpenter, D.M.; Leggett, S.H.; Jones, A.; MacMillan, M.; Fulton, M. Quantitative
assessment of full range of motion isometric lumbar extension strength. Spine 1990, 15, 289–294. [CrossRef]
[PubMed]
38. Robinson, M.E.; Greene, A.F.; O’Connor, P.; Graves, J.E.; MacMillan, M. Reliability of lumbar isometric torque
in patients with chronic low back pain. Phys. Ther. 1992, 72, 186–190. [CrossRef] [PubMed]
39. Inanami, H. Iwai Orthopedic Hospital rehabilitation program [abstract]. Presented at International Spinal
Rehabilitation Update 1991 Symposium, Daytona, FL, USA, 12–14 September 1991.
40. Pollock, M.L.; Graves, J.E.; Leggett, S.H.; Young, W.G.; Gazzarella, Z.; Carpenter, D.M.; Carroll, J.; Braith, R.;
Limacher, M. Accuracy of counter weighting to account for upper body mass in testing lumbar extension
strength. Med. Sci. Sports Exerc. 1991, 23, 66.
41. Ogon, M.; Krismer, M.; Sollner, W.; Kantner-Rumplmair, W.; Lampe, A. Chronic low back pain measurement
with visual analogue scales in different settings. Pain 1996, 64, 425–428. [CrossRef]
42. Fairbank, J.C.; Couperm, J.; Davies, J.B.; O’Brien, J.P. The Oswestry low back pain disability questionnaire.
Physiotherapy 1980, 66, 271–273. [PubMed]
43. Steele, J.; Fisher, J.; Giessing, J.; Gentil, P. Clarity in reporting terminology and definitions of set endpoints in
resistance training. Muscle Nerve 2017, 56, 368–374. [CrossRef] [PubMed]
44. Atkinson, G.; Batterham, A.M. True and false interindividual differences in the physiological response to an
intervention. Exp. Physiol. 2015, 100, 577–588. [CrossRef] [PubMed]
45. Ostelo, R.W.J.G.; Deyo, R.A.; Stratford, P.; Waddell, G.; Croft, P.; Von Korff, M.; Bouter, L.M.; de Vet, H.C.
Interpreting change scores for pain and functional status in low back pain: Towards international consensus
regarding minimal important change. Spine 2008, 33, 90–94. [CrossRef] [PubMed]
46. Hubal, M.J.; Gordish-Dressman, H.; Thompson, P.D.; Price, T.B.; Hoffman, E.P.; Angelopoulos, T.J.;
Gordon, P.M.; Moyna, N.M.; Pescatello, L.S.; Visich, P.S.; et al. Variability in muscle size and strength
after unilateral resistance training. Med. Sci. Sports Exerc. 2005, 37, 964–972. [PubMed]
47. Rittweger, J.; Just, K.; Kautzsch, K.; Reeq, P.; Felsenberg, D. Treatment of chronic lower back pain with lumbar
extension and whole-body vibration exercise: a randomized controlled trial. Spine 2002, 27, 1829–1834.
[CrossRef] [PubMed]
48. Matheson, L.; Leggett, S.; Mooney, V.; Schneider, K.; Mayer, J. Contributions of aerobic fitness and back
strength to lift capacity. Spine 2002, 27, 1208–1212. [CrossRef] [PubMed]
49. Reyna, J.R.; Leggett, S.H.; Kenney, K.; Holmes, B.; Mooney, V. The effect of lumbar belts on isolated lumbar
muscle. Strength and dynamic capacity. Spine 1995, 20, 68–73. [CrossRef] [PubMed]
Healthcare 2017, 5, 75 15 of 15
50. Al Obaidi, S.M.; Nelson, R.M.; Al-Awadhi, S.; Al-Shuwaie, N. The role of anticipation and fear of pain in
the persistence of avoidance behaviour in patients with chronic low back pain. Spine 2000, 25, 1126–1131.
[CrossRef] [PubMed]
51. Giessing, J.; Eichmann, B.; Steele, J.; Fisher, J. A comparison of low volume ‘high-intensity-training’ and high
volume traditional resistance training methods on muscular performance, body composition, and subjective
assessments of training. Biol. Sport 2016, 33, 241–249. [CrossRef] [PubMed]
52. Giessing, J.; Fisher, J.; Steele, J.; Rothe, F.; Raubold, K.; Eichmann, B. The effects of low volume resistance
training with and without advanced techniques in trained subjects. J. Sports Med. Phys. Fitness 2016, 56,
249–258.
53. Willemink, M.J.; van Es, H.W.; Helmhout, P.H.; Diederik, A.L.; Kelder, J.C.; van Heesewijk, J.P. The effects
of dynamic isolated lumbar extensor training on lumbar multifidus functional cross-sectional area and
functional status of patients with chronic nonspecific low back pain. Spine 2012, 37, E1651–E1658. [CrossRef]
[PubMed]
54. Choi, G.; Raiturker, P.P.; Kim, M.J.; Chung, D.J.; Chae, Y.S.; Lee, S.H. The effect of early isolated lumbar
extension exercise program for patients with herniated disc undergoing lumbar discectomy. Neurosurgery
2005, 57, 764–772. [CrossRef] [PubMed]
55. Mooney, V.; Gulick, J.; Perlman, M.; Levy, D.; Pozos, R.; Leggett, S.; Resnick, D. Relationships between
myoelectric activity, strength and MRI of lumbar extensor muscles in back pain patients and normal subjects.
J. Spinal Disord. 1997, 10, 348–356. [CrossRef] [PubMed]
56. Steele, J.; Bruce-Low, S.; Smith, D.; Willemink, M.J.; van Es, H.W.; Helmhout, P.H. The effects of dynamic
isolated lumbar extensor training on lumbar multifidus functional cross-sectional area and functional status
of patients with chronic nonspecific low back pain. Spine 2013, 38, 1609–1610. [CrossRef] [PubMed]
57. Ford, J.J.; Hahne, A.J. Pathoanatomy and classification of low back disorders. Man. Ther. 2013, 18, 165–168.
[CrossRef] [PubMed]
58. Risch, S.V.; Norvell, N.K.; Pollock, M.L.; Risch, E.D.; Langer, H.; Fulton, M.; Graves, J.E.; Leggett, S.H.
Lumbar strengthening in chronic low back pain patients. Spine 1993, 18, 232–238. [CrossRef] [PubMed]
59. Kent, P.; Keating, J. Do primary-care clinicians think that non-specific low back pain is one condition? Spine
2004, 29, 1022–1031. [CrossRef] [PubMed]
60. Ford, J.; Thompson, S.; Hahne, A. A classification and treatment protocol for low back disorders. Part 1.
Specific manual therapy. Phys. Ther. Rev. 2012, 16, 168–177. [CrossRef]
61. Ford, J.; Surkitt, L.; Hahne, A. A classification and treatment protocol for low back disorders. Part 2.
Directional preference management for reducible discogenic pain. Phys. Ther. Rev. 2012, 16, 423–437.
[CrossRef]
62. Ford, J.; Hahne, A.; Chan, A.; Surkitt, L. A classification and treatment protocol for low back disorders. Part 3.
Functional restoration for intervertebral disc related disorders. Phys. Ther. Rev. 2012, 17, 55–75. [CrossRef]
63. Ford, J.; Richards, M.; Hahne, A. A classification and treatment protocol for low back disorders. Part 4.
Functional restoration for low back disorders associated with multifactorial persistent pain. Phys. Ther. Rev.
2012, 17, 322–334. [CrossRef]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
